Role of the RNA-binding protein HuR in human renal cell carcinoma

Carcinogenesis

Volumn 31, Issue 6, 2010, Pages 1018-1026

  Danilin, Sabrina ^a   Sourbier, Carole ^a   Thomas, Lionel ^a   Lindner, Véronique ^b   Rothhut, Sylvie ^a   Dormoy, Valérian ^a   Helwig, Jean Jacques ^a   Jacqmin, Didier ^c   Lang, Hervé ^c   Massfelder, Thierry ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b CENTRE HOSPITALIER DE MULHOUSE   (France)

^c HÔPITAL CIVIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUR PROTEIN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RNA BINDING PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN; ELAV-LIKE PROTEIN 1; MEMBRANE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY BIOPSY; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; GENE SILENCING; GENETICS; KIDNEY TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, SURFACE; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; HUMANS; KIDNEY NEOPLASMS; MICE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

EID: 77953921408     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq052     Document Type: Article

References (48)

1. Clark, P.E. (2007) Recent advances in targeted therapy for renal cell carcinoma. Curr. Opin. Urol., 17, 331-336.
2. Sourbier, C. et al. (2006) Parathyroid hormone-related protein in human renal cell carcinoma. Cancer Lett., 240, 170-182.
3. Motzer, R.J. et al. (2000) Systemic therapy for renal cell carcinoma. J. Urol., 163, 408-417.
4. Escudier, B. et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N. Engl. J. Med., 356, 125-134.
5. Motzer, R.J. et al. (2007) Sunitinib versus interferon alfa in metastatic renalcell carcinoma. N. Engl. J. Med., 356, 115-124.
6. Friedrich, C.A. (1999) Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer, 86, 2478-2482.
7. Kaelin, W.G.Jr (2007) The von hippel-lindau tumor suppressor protein: An update. Methods Enzymol., 435, 371-383.
8. Abdelmohsen, K. et al. (2007) Posttranscriptional orchestration of an antiapoptotic program by HuR. Cell Cycle, 6, 1288-1292.
9. Lopez de Silanes, I. et al. (2005) HuR: Post-transcriptional paths to malignancy. RNA Biol., 2, 11-13.
10. Bevilacqua, A. et al. (2003) Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J. Cell Physiol., 195, 356-372.
11. Eberhardt, W. et al. (2007) Modulation of mRNA stability as a novel therapeutic approach. Pharmacol. Ther., 114, 56-73.
12. Mitchell, P. et al. (2001) mRNA turnover. Curr. Opin. Cell Biol., 13, 320-325.
13. Galban, S. et al. (2008) RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol. Cell. Biol., 28, 93-107.
14. Danilin, S. et al. (2009) von Hippel-Lindau tumor suppressor genedependent mRNA stabilization of the survival factor parathyroid hormonerelated protein in human renal cell carcinoma by the RNA-binding protein HuR. Carcinogenesis, 30, 387-396.
15. Blaxall, B.C. et al. (2000) Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol. Carcinog., 28, 76-83.
16. Denkert, C. et al. (2006) Expression of the ELAV-like protein HuR in human colon cancer: Association with tumor stage and cyclooxygenase-2. Mod. Pathol., 19, 1261-1269.
17. Erkinheimo, T.L. et al. (2003) Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res., 63, 7591-7594.
18. Heinonen, M. et al. (2005) Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res., 65, 2157-2161.
19. Lopez de Silanes, I. et al. (2003) Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene, 22, 7146-7154.
20. Sheflin, L.G. et al. (2004) Androgens regulate the binding of endogenous HuR to the AU-rich 3#UTRs of HIF-1alpha and EGF mRNA. Biochem. Biophys. Res. Commun., 322, 644-651.
21. Datta, K. et al. (2005) Role of elongin-binding domain of von Hippel Lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinoma. Oncogene, 24, 7850-7858.
22. Massfelder, T. et al. (2004) Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene. Cancer Res., 64, 180-188.
23. Agouni, A. et al. (2007) Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: Evidence for a critical role for integrin-linked kinase and nuclear factor kappa B. Carcinogenesis, 28, 1893-1901.
24. Sourbier, C. et al. (2007) Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy. Cancer Res., 67, 11668-11676.
25. Sourbier, C. et al. (2006) The phosphoinositide 3-kinase/Akt pathway: A new target in human renal cell carcinoma therapy. Cancer Res., 66, 5130-5142.
26. Talon, I. et al. (2006) Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo. Carcinogenesis, 27, 73-83.
27. Lowry, O.H. et al. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
28. Huang, D. et al. (2008) Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res., 68, 81-88.
29. Fan, X.C. et al. (1998) HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc. Natl Acad. Sci. USA, 95, 15293-15298.
30. Doller, A. et al. (2007) Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: Implications for posttranscriptional regulation of cyclooxygenase-2. Mol. Biol. Cell, 18, 2137-2148.
31. Ming, X.F. et al. (2001) Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogenactivated protein kinase. Mol. Cell. Biol., 21, 5778-5789.
32. Pascale, A. et al. (2005) Neuronal ELAV proteins enhance mRNA stability by a PKCalpha-dependent pathway. Proc. Natl Acad. Sci. USA, 102, 12065-12070.
33. Wang, W. et al. (2002) AMP-activated kinase regulates cytoplasmic HuR. Mol. Cell. Biol., 22, 3425-3436.
34. Wang, W. et al. (2004) AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1: Involvement in the nuclear import of RNA-binding protein HuR. J. Biol. Chem., 279, 48376-48388.
35. Winzen, R. et al. (1999) The p38 MAP kinase pathway signals for cytokineinduced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J., 18, 4969-4980.
36. Brenner, W. et al. (2003) Protein kinase C eta is associated with progression of renal cell carcinoma (RCC). Anticancer Res., 23, 4001-4006.
37. Ma, W.J. et al. (1997) Localization of the human HuR gene to chromosome 19p13.2. Hum. Genet., 99, 32-33.
38. Ibrahim, H. et al. (2008) Renal response to metabolic acidosis: Role of mRNA stabilization. Kidney Int., 73, 11-18.
39. Jeyaraj, S.C. et al. (2006) Expression and distribution of HuR during ATP depletion and recovery in proximal tubule cells. Am. J. Physiol. Renal Physiol., 291, F1255-F1263.
40. Galban, S. et al. (2003) Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells. Mol. Cell. Biol., 23, 7083-7095.
41. Mazan-Mamczarz, K. et al. (2003) RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc. Natl Acad. Sci. USA, 100, 8354-8359.
42. Al-Mohanna, M.A. et al. (2007) The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light. Nucleic Acids Res., 35, 223-233.
43. Dong, R. et al. (2007) Stabilization of Snail by HuR in the process of hydrogen peroxide induced cell migration. Biochem. Biophys. Res. Commun., 356, 318-321.
44. Dormoy-Raclet, V. et al. (2007) The RNA-binding protein HuR promotes cell migration and cell invasion by stabilizing the beta-actin mRNA in a Urich-element-dependent manner. Mol. Cell. Biol., 27, 5365-5380.
45. Guo, X. et al. (2006) HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells. Cancer Res., 66, 7948-7956.
46. Lal, A. et al. (2005) Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha. EMBO J., 24, 1852-1862.
47. Carroll, V.A. et al. (2006) Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway. Cancer Res., 66, 6264-6270.
48. Meisner, N.C. et al. (2007) Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat. Chem. Biol., 3, 508-515.